E-LIB Suche - Ergebnisse für: Parakh, Sagun

1

Implementation of a nurse-led, multidisciplinary model of c..:

Dufton, Polly Hypatia ; Tarasenko, Elena ; Midgley, Katrina...
BMJ Open. 14 (2024) 1 - p. e077005 , 2024

Link: https://doi.org/10.1136/..

2

Lurbinectedin in small cell lung cancer: real‐world experie..:

Alexander, Marliese ; Rogers, Jennifer ; Parakh, Sagun...
Internal Medicine Journal. 54 (2024) 7 - p. 1087-1096 , 2024

Link: https://doi.org/10.1111/..

3

A Phase II trial of alternating osimertinib and gefitinib t..:

Tan, Lavinia ; Brown, Chris ; Mersiades, Antony...
Nature Communications. 15 (2024) 1 - p. , 2024

Link: https://doi.org/10.1038/..

4

ALKTERNATE: A Pilot Study Alternating Lorlatinib With Crizo..:

Itchins, Malinda ; Liang, Shirley ; Brown, Chris...
JTO Clinical and Research Reports. 5 (2024) 9 - p. 100703 , 2024

Link: https://doi.org/10.1016/..

5

Real-World Analysis of Clinical Characteristics and Surviva..:

Wang, Yang ; Mathai, Jared ; Alamgeer, Muhammad...
JTO Clinical and Research Reports. 4 (2023) 8 - p. 100544 , 2023

Link: https://doi.org/10.1016/..

6

PD-L1 Positron Emission Tomography Imaging in Patients With..:

Hegi-Johnson, Fiona ; Rudd, Stacey E. ; Wichmann, Christian W....
International Journal of Radiation Oncology*Biology*Physics. 117 (2023) 3 - p. 675-682 , 2023

Link: https://doi.org/10.1016/..

7

Editorial: Overcoming drug relapse and therapy resistance i..:

Parakh, Sagun ; Leong, Tracy L. ; Best, Sarah A..
Frontiers in Oncology. 13 (2023) - p. , 2023

Link: https://doi.org/10.3389/..

8

LOREALAUS: LOrlatinib REAL-World AUStralian Experience in A..:

Alexander, Marliese ; Wei, Joe ; Parakh, Sagun...
JTO Clinical and Research Reports. 4 (2023) 4 - p. 100490 , 2023

Link: https://doi.org/10.1016/..

9

The systemic management of central nervous system metastase..:

Senko, Clare ; Gunjur, Ashray ; Balasubramanian, Adithya...
Asia-Pacific Journal of Clinical Oncology. 18 (2022) 6 - p. 515-525 , 2022

Link: https://doi.org/10.1111/..

10

Primary CNS lymphoma in the real world—Opportunities for im..:

Parakh, Sagun ; Gan, Hui K
Neuro-Oncology Practice. 9 (2022) 3 - p. 159-160 , 2022

Link: https://doi.org/10.1093/..

11

Antibody-drug conjugates: beyond current approvals and pote..:

Menon, Siddharth ; Parakh, Sagun ; Scott, Andrew M..
Exploration of Targeted Anti-tumor Therapy. , 2022

Link: https://doi.org/10.37349..

12

Poor correlation between preclinical and patient efficacy d..:

Gunjur, Ashray ; Balasubramanian, Adithya ; Hafeez, Umbreen...
Journal of Neuro-Oncology. 159 (2022) 3 - p. 539-549 , 2022

Link: https://doi.org/10.1007/..

13

Correction to: Poor correlation between preclinical and pat..:

Gunjur, Ashray ; Balasubramanian, Adithya ; Hafeez, Umbreen...
Journal of Neuro-Oncology. 159 (2022) 3 - p. 551-551 , 2022

Link: https://doi.org/10.1007/..

14

A Multi-Center Real-World Experience of IMpower150 in Oncog..:

Itchins, Malinda ; Ainsworth, Hannah ; Alexander, Marliese...
Clinical Lung Cancer. 23 (2022) 8 - p. 702-708 , 2022

Link: https://doi.org/10.1016/..

15

Adult medulloblastoma in an Australian population:

Parakh, Sagun ; Davies, Amy ; Westcott, Kerryn...
Journal of Clinical Neuroscience. 102 (2022) - p. 65-70 , 2022

Link: https://doi.org/10.1016/..